These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22450837)

  • 21. [SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION AS A SIDE EFFECT OF CHEMOTHERAPY FOR URACHAL CARCINOMA: A CASE REPORT].
    Maeda K; Mori Y; Nakamura M; Harada Y; Kodama K
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):100-104. PubMed ID: 35444077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A Case of Severe Hyponatremia Caused by Renal Salt Wasting Syndrome in Oropharyngeal Cancer].
    Fujikawa T; Shirakura S; Hatanaka A; Okano W; Tokumaru T; Yamada M; Saito Y; Beppu T
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Aug; 118(8):1046-52. PubMed ID: 26548098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early measurement of urinary N-acetyl-β-glucosaminidase helps predict severe hyponatremia associated with cisplatin-containing chemotherapy.
    Arakawa Y; Tamura M; Sakuyama T; Aiba K; Eto S; Yuda M; Tanaka Y; Matsumoto A; Nishikawa K
    J Infect Chemother; 2015 Jul; 21(7):502-6. PubMed ID: 25851853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of cerebral polyuric hyponatremia (author's transl)].
    Shishido T; Goma T; Zenke M; Motozaki T; Mori Y; Sakaki S; Matsuoka K
    No Shinkei Geka; 1978 May; 6(5):491-7. PubMed ID: 662077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin.
    Shimada A; Takeuchi H; Fukuda K; Suda K; Nakamura R; Wada N; Kawakubo H; Kitagawa Y
    Esophagus; 2018 Oct; 15(4):209-216. PubMed ID: 30225740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
    Abdelghani L; Modha K; Albaddawi E; Subramanian S
    J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerebral salt wasting syndrome in children with acute central nervous system injury.
    Jiménez R; Casado-Flores J; Nieto M; García-Teresa MA
    Pediatr Neurol; 2006 Oct; 35(4):261-3. PubMed ID: 16996399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of severe electrolytic disorder after adjuvant chemotherapy for esophageal cancer].
    Fukuhara K; Omura T; Katsuragi K; Osugi H; Lee S; Kishida S
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1359-61. PubMed ID: 19692779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cerebral salt wasting syndrome secondary to head injury: a case report].
    Kawajiri K; Matsuoka Y; Kan M
    No Shinkei Geka; 1992 Sep; 20(9):1003-7. PubMed ID: 1407351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of urachal carcinoma treated with S-1/CDDP combination chemotherapy].
    Sekita N; Fujimura M; Arai H; Shibata N; Nishikawa R; Sugano I; Mikami K
    Hinyokika Kiyo; 2010 Aug; 56(8):447-51. PubMed ID: 20808064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Marked hyponatremia with consciousness disturbance probably caused by linezolid in a patient with acute myeloid leukemia].
    Suzuki K; Ohishi K; Ino K; Sugawara Y; Sekine T
    Kansenshogaku Zasshi; 2008 Jan; 82(1):38-42. PubMed ID: 18306678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
    Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Severe hyperbilirubinemia after cisplatin-based chemotherapy].
    Onishi Y; Hatae M; Matsuda Y; Nakamura T; Kodama Y; Itoh M; Maruyama H; Maeda Y
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1103-6. PubMed ID: 7611762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of different methods of estimating renal function on determining eligibility for cisplatin (CDDP)-based chemotherapy in patients with invasive urothelial carcinoma].
    Goto T; Yoshimura K; Matsui Y; Shimizu Y; Inoue T; Okubo K; Kamba T; Nishiyama H; Ogawa O
    Hinyokika Kiyo; 2011 Dec; 57(12):671-6. PubMed ID: 22240299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective study of hyponatremia in tetraplegic/paraplegic patients with a review of the literature.
    Soni BM; Vaidyanthan S; Watt JW; Krishnan KR
    Paraplegia; 1994 Sep; 32(9):597-607. PubMed ID: 7997339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyponatremia with high plasma ANP level--report of two cases with emphasis on the pathophysiology of cerebral salt wasting].
    Yamamoto N; Miyamoto N; Seo H; Matsui N; Kuwayama A; Terashima K
    No Shinkei Geka; 1987 Sep; 15(9):1019-23. PubMed ID: 2962007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin increases urinary sodium excretion in rats: gender-related differences.
    Stakisaitis D; Dudeniene G; Jankūnas RJ; Grazeliene G; Didziapetriene J; Pundziene B
    Medicina (Kaunas); 2010; 46(1):45-50. PubMed ID: 20234163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of central pontine myelinolysis].
    Shimoda M; Matsuoka T; Kato T; Ueda M; Yamamoto I; Tsugane R; Sato O
    No Shinkei Geka; 1986 Jul; 14(8):1031-7. PubMed ID: 3748296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cerebral salt wasting syndrome in a patient with viral meningoencephalitis].
    Namba T; Harada T; Sakai K; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2006; 48(7):669-74. PubMed ID: 17128884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.